270 related articles for article (PubMed ID: 38639185)
1. The role of ferroptosis in radiotherapy and combination therapy for head and neck squamous cell carcinoma (Review).
Feng Y; Li X; Yang B; Li M; Du Y; Wang J; Liu S; Gong L; Li L; Gao L
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38639185
[TBL] [Abstract][Full Text] [Related]
2. Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma.
Song A; Wu L; Zhang BX; Yang QC; Liu YT; Li H; Mao L; Xiong D; Yu HJ; Sun ZJ
Cancer Lett; 2024 Apr; 588():216727. PubMed ID: 38431035
[TBL] [Abstract][Full Text] [Related]
3. SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1.
Xu X; Mao Y; Feng Z; Dai F; Gu T; Zheng J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186303
[TBL] [Abstract][Full Text] [Related]
4. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
Alsahafi EN; Thavaraj S; Sarvestani N; Novoplansky O; Elkabets M; Ayaz B; Tavassoli M; Legends MF
Cancer Lett; 2021 Feb; 498():80-97. PubMed ID: 33137407
[TBL] [Abstract][Full Text] [Related]
5. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
[TBL] [Abstract][Full Text] [Related]
6. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
[TBL] [Abstract][Full Text] [Related]
7. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
8. Tris(8-Hydroxyquinoline)iron induces apoptotic cell death via oxidative stress and by activating death receptor signaling pathway in human head and neck carcinoma cells.
Chan LP; Tseng YP; Ding HY; Pan SM; Chiang FY; Wang LF; Chou TH; Lien PJ; Liu C; Kuo PL; Liang CH
Phytomedicine; 2019 Oct; 63():153005. PubMed ID: 31302316
[TBL] [Abstract][Full Text] [Related]
9. Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review).
Yang M; Guo R; Chen X; Song G; Zhang F
Int J Mol Med; 2023 Jun; 51(6):. PubMed ID: 37052257
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 promotes cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma.
Lu T; Zhang Z; Pan X; Zhang J; Wang X; Wang M; Li H; Yan M; Chen W
J Oral Pathol Med; 2022 Jan; 51(1):52-62. PubMed ID: 34874578
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
Odhiambo DA; Pittman AN; Rickard AG; Castillo RJ; Bassil AM; Chen J; Ravotti ML; Xu ES; Himes JE; Daniel AR; Watts TL; Williams NT; Luo L; Kirsch DG; Mowery YM
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1315-1327. PubMed ID: 38104870
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer.
Chung CH; Lin CY; Chen CY; Hsueh CW; Chang YW; Wang CC; Chu PY; Tai SK; Yang MH
Adv Sci (Weinh); 2023 May; 10(15):e2204514. PubMed ID: 37026630
[TBL] [Abstract][Full Text] [Related]
13. Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis.
Starska-Kowarska K
Nutrients; 2023 May; 15(11):. PubMed ID: 37299554
[TBL] [Abstract][Full Text] [Related]
14. Combined EGFR1 and PARP1 Inhibition Enhances the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Models.
Frederick BA; Gupta R; Atilano-Roque A; Su TT; Raben D
Radiat Res; 2020 Nov; 194(5):519-531. PubMed ID: 32936912
[TBL] [Abstract][Full Text] [Related]
15. PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models.
Hernandez AL; Young CD; Bian L; Weigel K; Nolan K; Frederick B; Han G; He G; Devon Trahan G; Rudolph MC; Jones KL; Oweida AJ; Karam SD; Raben D; Wang XJ
Clin Cancer Res; 2020 Jun; 26(12):3058-3070. PubMed ID: 32139402
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy in head and neck cancer - scientific rationale, current treatment options and future directions.
Rothschild U; Muller L; Lechner A; Schlösser HA; Beutner D; Läubli H; Zippelius A; Rothschild SI
Swiss Med Wkly; 2018; 148():w14625. PubMed ID: 29756633
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.
Cripps C; Winquist E; Devries MC; Stys-Norman D; Gilbert R;
Curr Oncol; 2010 Jun; 17(3):37-48. PubMed ID: 20567625
[TBL] [Abstract][Full Text] [Related]
18. Integration of molecular targeted therapy with radiation in head and neck cancer.
Du Y; Peyser ND; Grandis JR
Pharmacol Ther; 2014 Apr; 142(1):88-98. PubMed ID: 24280066
[TBL] [Abstract][Full Text] [Related]
19. MTDH enhances radiosensitivity of head and neck squamous cell carcinoma by promoting ferroptosis based on a prognostic signature.
Cao X; Ge Y; Yan Z; Hu X; Peng F; Zhang Y; He X; Zong D
J Radiat Res; 2024 Jan; 65(1):10-27. PubMed ID: 37981296
[TBL] [Abstract][Full Text] [Related]
20. Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab.
Liu S; Yan S; Zhu J; Lu R; Kang C; Tang K; Zeng J; Ding M; Guo Z; Lai X; Jiang Y; Wu S; Zhou L; Sun L; Zhou ZW
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
